Detection of Beta-Catenin Protein Expression and Gene Mutation in Tumorigenesis of Endometrioid Adenocarcinoma

Yan XIONG,Yongyan XIONG,Hui HUANG,Yunfeng ZHOU

2009-01-01

Abstract:Objective:To detect the protein expression and the exon 3 mutation of β-catenin in benign hyperplasia,endometrial intraepithelial neoplasia (EIN),and endometrioid adenocarcinoma,and to investigate the relationship between abnormal expression and exon 3 mutation of β-catenin in carcinogenesis of endometrioid adenocarcinoma. Methods:A total of 117 endometrial samples (10 proliferative endometrium,59 benign hyperplasia,24 EIN,and 24 endometrioid adenocarcinoma) were involved in this study. Expression of β-catenin protein was detected by immunohistochemistry. DNA sequence alterations of exon 3 of β-catenin gene were investigated by polymerase chain reaction (PCR) and direct sequencing. Results:① Normal (membranous) expression of β-catenin presents in all the 10 cases of proliferative endometrium. While 6 of 59 benign hyperplasia cases (10.2%) showed abnormal (marked membranous/cytoplasmic and/or nuclear or negative) expression of β-catenin. Abnormal expression rate of β-catenin was 50.0% in 24 cases of EIN,and 66.7% in 24 cases of endometrioid adenocarcinoma respectively. Membranous/cytoplasmic expression of β-catenin was a predominant pattern for abnormal expressions in EIN and endometrioid adenocarcinoma. ② PCR and direct sequencing failed to reveal any exon 3 mutation of β-catenin gene in 117 endometrial specimens (particularly in benign hyperplasia,EIN,and endometrioid adenocarcinoma). Conclusion:①abnormal expression of β-catenin may be a useful marker in distinguishing benign hyperplasia from EIN and endometrioid adenocarcinoma. ②The exon 3 mutation of β-catenin gene may not be an important cause,which result in abnormal expression of β-catenin and tumorigenesis of endometrioid adenocarcinoma.